Houston Concierge Medicine and Cardio Diagnostics partner for early cardiovascular detection

It will add the Epi+Gen CHD test to its Executive Health Program

Heart disease is the leading cause of death in the United States for both men and women, and for most racial and ethnic groups. In fact, in this country one person dies every 36 seconds from cardiovascular disease, so early detection could literally be the difference between life and death.

To help identify those at risk for coronary heart disease, Cardio Diagnostics Holdings, a precision cardiovascular diagnostics company, has developed the Epi+Gen CHD test, which combines epigenetics, genetics, high-throughput computing and AI.

The test, which can be done at home, provides personalized insights based on genetic and epigenetic DNA biomarkers, which are unique to that person, for personalized treatment.

Now the company is expanding its reach through a partnership announced Wednesday with Houston Concierge Medicine, a medical practice serving executives and consumers in Houston, which will use the Epi+Gen CHD test in its Executive Health program.

When a patient requests an Epi+Gen CHD test from one of Cardio’s telemedicine providers, they are asked to complete an assessment to determine eligibility. Once their sample is processed, their results will be reviewed by a clinician to help create a personalized prevention plan, and the patient will be able to schedule a private, telemedicine consultation with that prescriber.

In addition to their genetics, Epi+Gen CHD also measures a patient’s epigenetic DNA biomarkers, which take into account how environment and lifestyle can affect heart health. The company analyzes its unique DNA biomarker information through its proprietary artificial intelligence algorithms to determine a patient’s likelihood of having coronary heart disease in the next three years.

“We are excited to partner with Dr. Burzinski and Houston Concierge Medicine,” said Meesha Dogan, MD, CEO and co-founder of Cardio Diagnostics.

“We have seen many innovative and agile providers in the concierge medicine space leading the adoption curve with Epi+Gen CHD. Organizations like Houston Concierge Medicine are encouraging the use of epigenomics to make precise and personalized health decisions for their busy patients.

For Houston Concierge Medicine, this partnership will allow them to expand their executive physicals, which can help identify and address potential health risks before they become serious. The goal is to reduce both medical costs and absenteeism over time.

“At Houston Concierge Medicine, we are committed to providing our patients with best-in-class diagnostic solutions. And since heart disease is top of mind for many of our clients who work in a fast-paced, stressful environment, the addition of Epi+Gen CHD will allow our practice to provide patients with objective and non-invasive tests to determine their risk for heart disease. We are proud to partner with Cardio Diagnostics,” said Dr. Greg Burzynski, founder and CEO of Houston Concierge Medicine, in a statement

(Image source: cardiodiagnosticsinc.com)


Also Read :  Midriff bulge linked to later physical decline, study says

Leave a Reply

Your email address will not be published.